• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏肿瘤学中的缺氧信号和氧代谢。

Hypoxia signaling and oxygen metabolism in cardio-oncology.

机构信息

UCSF Department of Medicine, Division of Cardiology, Section of Cardio-Oncology and Immunology, United States of America.

出版信息

J Mol Cell Cardiol. 2022 Apr;165:64-75. doi: 10.1016/j.yjmcc.2021.12.013. Epub 2022 Jan 1.

DOI:10.1016/j.yjmcc.2021.12.013
PMID:34979102
Abstract

Cardio-oncology is a rapidly growing field in cardiology that focuses on the management of cardiovascular toxicities associated with cancer-directed therapies. Tumor hypoxia is a central driver of pathologic tumor growth, metastasis, and chemo-resistance. In addition, conditions that mimic hypoxia (pseudo-hypoxia) play a causal role in the pathogenesis of numerous types of cancer, including renal cell carcinoma. Therefore, therapies targeted at hypoxia signaling pathways have emerged over the past several years. Though efficacious, these therapies are associated with significant cardiovascular toxicities, ranging from hypertension to cardiomyopathy. This review focuses on oxygen metabolism in tumorigenesis, the role of targeting hypoxia signaling in cancer therapy, and the relevance of oxygen metabolism in cardio-oncology. This review will specifically focus on hypoxia signaling mediated by hypoxia-inducible factors and the prolyl hydroxylase oxygen-sensing enzymes, the cardiovascular effects of specific cancer targeted therapies mediated on VEGF and HIF signaling, hypoxic signaling in cardiovascular disease, and the role of oxygen in anthracycline cardiotoxicity. The implications of these therapies on myocardial biology and cardiac function are discussed, underlining the fine balance of hypoxia signaling in cardiac homeostasis. Understanding these cardiovascular toxicities will be important to optimize treatment for cancer patients while mitigating potentially severe cardiovascular side effects.

摘要

肿瘤心脏病学是心脏病学中一个快速发展的领域,专注于管理癌症靶向治疗相关的心血管毒性。肿瘤缺氧是病理性肿瘤生长、转移和化疗耐药的主要驱动因素。此外,模拟缺氧的条件(假性缺氧)在多种类型的癌症发病机制中起着因果作用,包括肾细胞癌。因此,过去几年出现了针对缺氧信号通路的治疗方法。虽然这些治疗方法有效,但它们与严重的心血管毒性相关,范围从高血压到心肌病。这篇综述重点介绍肿瘤发生中的氧代谢、靶向缺氧信号在癌症治疗中的作用以及氧代谢在肿瘤心脏病学中的相关性。这篇综述将特别关注缺氧诱导因子介导的缺氧信号和脯氨酰羟化酶氧感应酶、血管内皮生长因子和缺氧诱导因子信号介导的特定癌症靶向治疗的心血管效应、心血管疾病中的缺氧信号以及氧在蒽环类药物心脏毒性中的作用。讨论了这些治疗方法对心肌生物学和心脏功能的影响,强调了缺氧信号在心脏稳态中的精细平衡。了解这些心血管毒性对于优化癌症患者的治疗同时减轻潜在严重的心血管副作用非常重要。

相似文献

1
Hypoxia signaling and oxygen metabolism in cardio-oncology.心脏肿瘤学中的缺氧信号和氧代谢。
J Mol Cell Cardiol. 2022 Apr;165:64-75. doi: 10.1016/j.yjmcc.2021.12.013. Epub 2022 Jan 1.
2
Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia.维持引擎运转:缺氧诱导因子作为缺血期间心脏代谢和血管生成的关键调节因子
J Mol Med (Berl). 2007 Dec;85(12):1309-15. doi: 10.1007/s00109-007-0279-x. Epub 2007 Nov 20.
3
From oxygen sensing to angiogenesis: Targeting the hypoxia signaling pathway in metastatic kidney cancer.从氧感应到血管生成:靶向转移性肾癌中的缺氧信号通路
Am J Health Syst Pharm. 2020 Dec 4;77(24):2064-2073. doi: 10.1093/ajhp/zxaa308.
4
Implications of Oxygen Homeostasis for Tumor Biology and Treatment.氧稳态对肿瘤生物学及治疗的影响
Adv Exp Med Biol. 2016;903:169-85. doi: 10.1007/978-1-4899-7678-9_12.
5
Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.实体瘤生理学与缺氧诱导的化学/放射抗性:癌症治疗的新策略:一氧化氮供体作为治疗增强剂
Nitric Oxide. 2008 Sep;19(2):205-16. doi: 10.1016/j.niox.2008.04.026. Epub 2008 May 6.
6
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.血清生物标志物在接受心脏毒性癌症治疗的癌症患者中的作用:心力衰竭协会的心脏肿瘤学研究小组和欧洲心脏病学会的心脏肿瘤学理事会的立场声明。
Eur J Heart Fail. 2020 Nov;22(11):1966-1983. doi: 10.1002/ejhf.2017. Epub 2020 Oct 20.
7
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).心血管影像学在接受心脏毒性治疗的癌症患者中的作用:代表心力衰竭协会(HFA)、欧洲心血管影像协会(EACVI)和欧洲心脏病学会心脏肿瘤学委员会(ESC)的立场声明。
Eur J Heart Fail. 2020 Sep;22(9):1504-1524. doi: 10.1002/ejhf.1957. Epub 2020 Aug 21.
8
The roles and signaling pathways of prolyl-4-hydroxylase 2 in the tumor microenvironment.脯氨酰-4-羟化酶 2 在肿瘤微环境中的作用及其信号通路。
Chem Biol Interact. 2019 Apr 25;303:40-49. doi: 10.1016/j.cbi.2019.02.019. Epub 2019 Feb 25.
9
The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.缺氧诱导因子在肿瘤代谢、生长和侵袭中的作用。
Bull Cancer. 2006 Aug;93(8):E73-80.
10
Cellular oxygen sensing need in CNS function: physiological and pathological implications.中枢神经系统功能中细胞氧感应的需求:生理和病理意义
J Exp Biol. 2004 Aug;207(Pt 18):3171-88. doi: 10.1242/jeb.01075.

引用本文的文献

1
Mesoporous silica nanoparticles with an azobenzene gatekeeper as hypoxia-responsive nanocarriers for targeted doxorubicin delivery.具有偶氮苯守门人的介孔二氧化硅纳米颗粒作为用于靶向递送阿霉素的缺氧响应性纳米载体。
Drug Deliv Transl Res. 2025 Aug 29. doi: 10.1007/s13346-025-01950-5.
2
Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer.对常氧条件下HIF-1稳定化的系统全面见解:对癌症细胞适应和治疗策略的启示
Cell Mol Biol Lett. 2025 Jan 6;30(1):2. doi: 10.1186/s11658-024-00682-7.
3
Cancer Therapy and Exercise Intolerance: The Heart Is But a Part: State-of-the-Art Review.
癌症治疗与运动不耐受:心脏只是其中一部分:最新综述
JACC CardioOncol. 2024 Jun 4;6(4):496-513. doi: 10.1016/j.jaccao.2024.04.006. eCollection 2024 Aug.
4
Drug resistance and tumor immune microenvironment: An overview of current understandings (Review).耐药性与肿瘤免疫微环境:当前认识概述(综述)。
Int J Oncol. 2024 Oct;65(4). doi: 10.3892/ijo.2024.5684. Epub 2024 Sep 2.
5
Cardiovascular Toxicity of Angiogenesis Inhibitors Among Patients With Cancer in Taiwan: A Nested Case-Control Study.台湾癌症患者血管生成抑制剂的心血管毒性:一项巢式病例对照研究。
J Am Heart Assoc. 2024 Jan 2;13(1):e030263. doi: 10.1161/JAHA.123.030263. Epub 2023 Dec 29.
6
Current Status and Trends of Research on Anthracycline-Induced Cardiotoxicity from 2002 to 2021: A Twenty-Year Bibliometric and Visualization Analysis.2002 年至 2021 年蒽环类药物心脏毒性研究的现状和趋势:二十年的文献计量学和可视化分析。
Oxid Med Cell Longev. 2022 Aug 11;2022:6260243. doi: 10.1155/2022/6260243. eCollection 2022.
7
Understanding Myocardial Metabolism in the Context of Cardio-Oncology.了解心血管肿瘤学背景下的心肌代谢
Heart Fail Clin. 2022 Jul;18(3):415-424. doi: 10.1016/j.hfc.2022.02.004.
8
The RNF26/CBX7 axis modulates the TNF pathway to promote cell proliferation and regulate sensitivity to TKIs in ccRCC.RNF26/CBX7 轴调节 TNF 通路以促进细胞增殖,并调节 ccRCC 对 TKI 的敏感性。
Int J Biol Sci. 2022 Feb 28;18(5):2132-2145. doi: 10.7150/ijbs.69325. eCollection 2022.